Okita N - Search Results

1

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer.

Takahari D, Shimada Y, Takeshita S, Nishitani H, Takashima A, Okita N, Hirashima Y, Kato K, Hamaguchi T, Yamada Y, Shirao K. Takahari D, et al. Among authors: okita n. Gastric Cancer. 2010 Aug;13(3):186-90. doi: 10.1007/s10120-010-0557-0. Epub 2010 Sep 5. Gastric Cancer. 2010. PMID: 20820988

2

Chemosensitivity of patients with recurrent esophageal cancer receiving perioperative chemotherapy.

Takashima A, Shirao K, Hirashima Y, Takahari D, Okita N, Akatsuka S, Nakajima TE, Matsubara J, Yasui H, Asakawa T, Kato K, Hamguchi T, Muro K, Yamada Y, Shimada Y. Takashima A, et al. Among authors: okita n. Dis Esophagus. 2008;21(7):607-11. doi: 10.1111/j.1442-2050.2008.00821.x. Epub 2008 Apr 22. Dis Esophagus. 2008. PMID: 18430178

3

Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.

Matsubara J, Yamada Y, Hirashima Y, Takahari D, Okita NT, Kato K, Hamaguchi T, Shirao K, Shimada Y, Shimoda T. Matsubara J, et al. Clin Cancer Res. 2008 May 15;14(10):3022-9. doi: 10.1158/1078-0432.CCR-07-1898. Clin Cancer Res. 2008. PMID: 18483367

4

A phase i study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer.

Matsubara J, Shimada Y, Takashima A, Takahari D, Hirashima Y, Okita NT, Nakajima TE, Kato K, Hamaguchi T, Yamada Y, Shirao K. Matsubara J, et al. Jpn J Clin Oncol. 2008 Aug;38(8):540-6. doi: 10.1093/jjco/hyn062. Epub 2008 Jul 15. Jpn J Clin Oncol. 2008. PMID: 18628316 Clinical Trial.

5

Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer.

Hirashima Y, Yamada Y, Matsubara J, Takahari D, Okita N, Takashima A, Kato K, Hamaguchi T, Shirao K, Shimada Y, Taniguchi H, Shimoda T. Hirashima Y, et al. Among authors: okita n. Cancer Sci. 2009 Feb;100(2):310-5. doi: 10.1111/j.1349-7006.2008.01020.x. Cancer Sci. 2009. PMID: 19068081 Free PMC article.

6

Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine.

Ono M, Shirao K, Takashima A, Morizane C, Okita N, Takahari D, Hirashima Y, Eguchi-Nakajima T, Kato K, Hamaguchi T, Yamada Y, Shimada Y. Ono M, et al. Among authors: okita n. Gastric Cancer. 2008;11(4):201-5. doi: 10.1007/s10120-008-0484-5. Epub 2009 Jan 8. Gastric Cancer. 2008. PMID: 19132481

7

Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.

Okita NT, Yamada Y, Takahari D, Hirashima Y, Matsubara J, Kato K, Hamaguchi T, Shirao K, Shimada Y, Taniguchi H, Shimoda T. Okita NT, et al. Jpn J Clin Oncol. 2009 Sep;39(9):595-600. doi: 10.1093/jjco/hyp066. Epub 2009 Jun 17. Jpn J Clin Oncol. 2009. PMID: 19535387

8

Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis.

Takashima A, Shirao K, Hirashima Y, Takahari D, Okita NT, Nakajima TE, Kato K, Hamaguchi T, Yamada Y, Shimada Y. Takashima A, et al. J Cancer Res Clin Oncol. 2010 Feb;136(2):243-8. doi: 10.1007/s00432-009-0655-8. J Cancer Res Clin Oncol. 2010. PMID: 19727819

9

Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma.

Okita NT, Kato K, Takahari D, Hirashima Y, Nakajima TE, Matsubara J, Hamaguchi T, Yamada Y, Shimada Y, Taniguchi H, Shirao K. Okita NT, et al. Gastric Cancer. 2011 Jun;14(2):161-5. doi: 10.1007/s10120-011-0025-5. Epub 2011 Feb 16. Gastric Cancer. 2011. PMID: 21327441

10

Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis.

Hirashima Y, Yamada Y, Tateishi U, Kato K, Miyake M, Horita Y, Akiyoshi K, Takashima A, Okita N, Takahari D, Nakajima T, Hamaguchi T, Shimada Y, Shirao K. Hirashima Y, et al. Among authors: okita n. Int J Cancer. 2012 May 15;130(10):2359-65. doi: 10.1002/ijc.26282. Epub 2011 Nov 28. Int J Cancer. 2012. PMID: 21780098 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters